Bone Biologics (BBLG) Accumulated Expenses (2016 - 2017)
Historic Accumulated Expenses for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $191667.0.
- Bone Biologics' Accumulated Expenses changed N/A to $191667.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $191667.0, marking a year-over-year change of. This contributed to the annual value of $41667.0 for FY2016, which is N/A changed from last year.
- Per Bone Biologics' latest filing, its Accumulated Expenses stood at $191667.0 for Q3 2017.
- Bone Biologics' Accumulated Expenses' 5-year high stood at $191667.0 during Q3 2017, with a 5-year trough of $41667.0 in Q4 2016.